A clickfesto-to-adlob, this piece had the challenge to balancing high-level data with human sustainability for a new class of breast cancer treatment that is kinder on the body while still fighting the disease.












A clickfesto-to-adlob, this piece had the challenge to balancing high-level data with human sustainability for a new class of breast cancer treatment that is kinder on the body while still fighting the disease.